Dean Slagel works as a venture capital investor at Esperante Ventures. The firm's known portfolio counts 7 companies.
Is Dean Slagel a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Contacts
Affiliated funds' portfolios
Affiliated at Esperante Ventures, whose known portfolio counts 7 companies
- Spiral Therapeutics
- Versantis
- Acousia Therapeutics
- Amlo Biosciences
- Oxford Cancer Biomarkers
- Arquer Diagnostics
- Pneumagen
Investor Profile
The listing covers sector Healthcare, and focus areas Biotech, Diagnostics, Drug Discovery and Pharma. Startups operating in these areas may find Dean Slagel relevant.
Stage-wise, the deals at Esperante Ventures cluster around Seed and Series B rounds.
The firm portfolio and the focus above give founders context on whether Dean Slagel matches their raise.
Frequently asked questions
Who is Dean Slagel?
Dean Slagel is a venture capital investor based in London, England, United Kingdom, listed at Esperante Ventures. The known portfolio of that firm counts 7 companies. That portfolio belongs to the firm, not to Dean Slagel personally.
What does Dean Slagel invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Diagnostics, Drug Discovery and Pharma. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Dean Slagel invest at?
Esperante Ventures appears in Seed and Series B rounds across its known deals, and Dean Slagel is listed there. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Dean Slagel listed at?
Dean Slagel is listed at Esperante Ventures, whose known portfolio counts 7 companies.
How do I contact Dean Slagel?
An email address and a LinkedIn page are on file for Dean Slagel. The address stays masked on this page and is readable inside RaiseHunt after you create an account. The database holds no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal